Clincosm LogoSign in Get a demo

Pregnancy Outcomes of Patients Having NC-FET Regarding the Progesterone Levels

Sponsor
Acibadem University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05690360
Collaborator
(none)
70
Enrollment
1
Location
9
Anticipated Duration (Months)
7.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

We recently identify in our previous study 'NCT052115832' the progesterone levels for the embryo transfer in natural thaw cycles. Since it is shown that progesterone levels work better than LH levels in order to detect the time to transfer, we aimed to show the pregnancy outcomes of the natural thaw cycles which had the transfer date regarding the progesterone levels.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    70 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Evaluation of the Pregnancy Outcomes and Time to Embryo Transfer Regarding the Progesterone Levels of Natural Cycle-FETs
    Actual Study Start Date :
    Nov 15, 2022
    Anticipated Primary Completion Date :
    Apr 15, 2023
    Anticipated Study Completion Date :
    Aug 15, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Cummulative Live Birth Rate [10 months]

      Live birth rates of Patient with NC-FET followed up with progesterone levels

    2. Biochemical pregnancy results [2 months]

      Biochemical pregnancy results of patients with NC-FET followed up with progesterone levels

    3. Pregnancy complications [10 months]

      Obstetric Complications of Patient with NC-FET followed up with progesterone levels

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 40 Years
    Sexes Eligible for Study:
    Female
    Inclusion Criteria:

    • patients with regular menstrual cycle

    • patients aged btw 20-40

    • patients with pregnancy with NC-FET by using the progesterone for the detection of ovulation

    Exclusion Criteria:

    • Spontenous pregnancies

    • Multiple pregnancies

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Acibadem University Atakent Hospital Istanbul Turkey 34303

    Sponsors and Collaborators

    • Acibadem University

    Investigators

    • Principal Investigator: NAZLI ALBAYRAK, MD, Acıbadem University School of Medicine
    • Principal Investigator: TURGUT AYDIN, MD, Acıbadem University School of Medicine
    • Principal Investigator: NADIYE KOROGLU, MD, Acıbadem University School of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Nazli Albayrak, Resident in training at Acibadem University, School of Medicine, Department of Obstetrics and Gynecology, Acibadem University
    ClinicalTrials.gov Identifier:
    NCT05690360
    Other Study ID Numbers:
    • 2022-17/60
    First Posted:
    Jan 19, 2023
    Last Update Posted:
    Jan 19, 2023
    Last Verified:
    Jan 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Infertility

    Study Results

    No Results Posted as of Jan 19, 2023